Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report sent to investors on Wednesday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

RVP opened at $0.62 on Wednesday. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.34. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The company has a market cap of $18.49 million, a P/E ratio of -1.14 and a beta of 2.06. The company has a fifty day moving average price of $0.72 and a two-hundred day moving average price of $0.93.

Insider Buying and Selling at Retractable Technologies

In related news, CEO Thomas J. Shaw purchased 71,422 shares of the firm’s stock in a transaction on Friday, September 20th. The stock was purchased at an average cost of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now owns 14,743,907 shares in the company, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders purchased 179,515 shares of company stock valued at $143,037. Corporate insiders own 55.00% of the company’s stock.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.